Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Camurus provides the global pharma and biotech industry with effective drug delivery technologies for peptides, proteins and insoluble small molecules, for the parenteral, oral and topical routes. More
Novel technological inventions for the prevention and treatment of staphylococcal infections in humans and animals. More
Probiodrug develops low-molecular weight organic molecules that modulate the activity of certain proteins as potential drugs. More
Medical School - Teaching Hospital - Research Institution More
LeadDiscovery offers intelligence services to the drug discovery sector. Focusing on pre-clinical research and analysis for identification and development of new therapeutic entities More
Genecom is the commercialisation arm of the Moredun Institute and the Institute for Animal Health. These institutes have international reputations in the area of animal health. More
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
ReGen is an early-stage biopharmaceutical company developing Colostrinin (a natural sourced material) for Alzheimers. Colostrinin may also have utility as a neutraceutical More
The IRC Network Biotechnology Thematic Group's goal is to contribute to the promotion of innovation in the European Biotechnology sector through technology transfer. More
Your selection
- Therapeutic target
- Immune related disorders del
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us